We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMNA
8101
DELISTED
ETRACS Alerian Midstream Energy Index ETN
AMNA
$4.22K ﹤0.01%
96
-100
-51% -$4.23K
WGSWW
8102
DELISTED
GeneDx Holdings Warrant
WGSWW
$4.21K ﹤0.01%
140,447
+4,774
+4% +$163
CLIX icon
8103
ProShares Long Online/Short Stores ETF
CLIX
$7.61M
$4.2K ﹤0.01%
+99
New +$4.17K
JANP icon
8104
PGIM US Large-Cap Buffer 12 ETF January
JANP
$47.5M
$4.18K ﹤0.01%
+153
New +$4.07K
QLVD icon
8105
FlexShares Developed Markets ex-US Quality Low Volatility Index Fund
QLVD
$54.8M
$4.18K ﹤0.01%
159
+73
+85% +$1.94K
JUNZ icon
8106
TrueShares Structured Outcome June ETF
JUNZ
$30.8M
$4.16K ﹤0.01%
143
CPOP icon
8107
Pop Culture Group
CPOP
$4.52M
$4.16K ﹤0.01%
293
-133
-31% -$2.3K
CNSP icon
8108
CNS Pharmaceuticals
CNSP
$8.46M
$4.15K ﹤0.01%
+4
New +$21.3K
EEV icon
8109
ProShares Trust UltraShort MSCI Emerging Markets
EEV
$2.52M
$4.13K ﹤0.01%
118
-292
-71% -$10.8K
PIXY
8110
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$4.12K ﹤0.01%
156
-96
-38% -$2.76K
TAGG icon
8111
T. Rowe Price QM US Bond ETF
TAGG
$2.33B
$4.11K ﹤0.01%
+98
New +$4.09K
NPWR.WS icon
8112
NET Power Inc Warrants
NPWR.WS
$16.1M
$4.08K ﹤0.01%
+1,785
New +$4.59K
DRMA icon
8113
Dermata Therapeutics
DRMA
$4.32M
$4.08K ﹤0.01%
+171
New +$7.44K
PSH icon
8114
PGIM Short Duration High Yield ETF
PSH
$172M
$4.07K ﹤0.01%
81
+79
+3,950% +$3.97K
LYRA
8115
DELISTED
LYRA THERAPEUTICS INC
LYRA
$4.07K ﹤0.01%
+294
New +$33.2K
TSBX
8116
DELISTED
Turnstone Biologics
TSBX
$4.06K ﹤0.01%
1,551
-17,506
-92% -$50K
DMBS icon
8117
DoubleLine Mortgage ETF
DMBS
$697M
$4.05K ﹤0.01%
84
+46
+121% +$2.2K
ROMA icon
8118
Roma Green Finance Ltd
ROMA
$555M
$4.03K ﹤0.01%
+6,400
New +$4.52K
PRT
8119
PermRock Royalty Trust Unit
PRT
$26.4M
$4.02K ﹤0.01%
1,033
-399
-28% -$1.57K
BUFC icon
8120
AB Conservative Buffer ETF
BUFC
$1.05B
$4.02K ﹤0.01%
+107
New +$3.94K
BKYI
8121
BIO-key International
BKYI
$4.08M
$4.01K ﹤0.01%
245
+201
+457% +$3.48K
HEAL
8122
Global X Funds Global X HealthTech ETF
HEAL
$29.4M
$3.98K ﹤0.01%
152
-153
-50% -$4.17K
AGRH icon
8123
iShares Interest Rate Hedged US Aggregate Bond ETF
AGRH
$7.88M
$3.97K ﹤0.01%
+153
New +$3.97K
HUSV icon
8124
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$74.1M
$3.97K ﹤0.01%
112
+28
+33% +$980
LIPO
8125
DELISTED
Lipella Pharmaceuticals
LIPO
$3.95K ﹤0.01%
+1,097
New +$5.99K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.